NCT02903966 - GSK2982772 Study in Subjects With Ulcerative Colitis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 15, 2016

Primary Completion Date

June 17, 2019

Study Completion Date

June 17, 2019

Conditions

Colitis, Ulcerative

Interventions

DRUG

GSK2982772

GSK2982772 is available as a 30 mg white to almost white, round film coated tablet which will be administered as two tablets three times a day as directed.

DRUG

Placebo

Placebo is available as a white to almost white, round film coated tablet which will be administered as two tablets three times a day as directed.

Trial Locations (23)

11021

GSK Investigational Site, Great Neck

48047

GSK Investigational Site, Chesterfield

70072

GSK Investigational Site, Marrero

78613

GSK Investigational Site, Cedar Park

89081

GSK Investigational Site, Ulm

92115

GSK Investigational Site, San Diego

92555

GSK Investigational Site, Moreno Valley

123098

GSK Investigational Site, Moscow

196247

GSK Investigational Site, Saint Pertersburg

236022

GSK Investigational Site, Kaliningrad

344091

GSK Investigational Site, Rostov-on-Don

355018

GSK Investigational Site, Stavropol

450071

GSK Investigational Site, Ufa

1105 AZ

GSK Investigational Site, Amsterdam

40-660

GSK Investigational Site, Katowice

95-054

GSK Investigational Site, Ksawerów

Unknown

GSK Investigational Site, Wroclaw

SE-171 76

GSK Investigational Site, Stockholm

SE-182 88

GSK Investigational Site, Stockholm

SE-752 37

GSK Investigational Site, Uppsala

SK2 7JE

GSK Investigational Site, Stockport

BT16 1RH

GSK Investigational Site, Belfast

DY1 2HQ

GSK Investigational Site, Dudley